<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01991275</url>
  </required_header>
  <id_info>
    <org_study_id>ITMRoboProstDMHong</org_study_id>
    <nct_id>NCT01991275</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine in Robot-assisted Prostatectomy</brief_title>
  <acronym>RoboITMProst</acronym>
  <official_title>The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the efficacy and safety of intrathecal morphine for the patients
      undergoing robot-assisted prostatectomy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prostatectomy is the treatment of choice for prostate cancer. The robot-assisted
      prostatectomy is becoming the most popular surgical method for prostate cancer. The small
      incision after robot-assisted prostatectomy is thought to reduce the postoperative pain.
      There is few investigations for the strategy to reduce the postoperative pain of
      robot-assisted prostatectomy.

      The intrathecal morphine injection is known to reduce postoperative pain for surgeries like
      hepatectomy, myomectomy and open prostatectomy. This method, however, is not yet studied for
      the robot-assisted prostatectomy. This study will investigate the efficacy and safety of
      intrathecal morphine for the patients undergoing robot-assisted prostatectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The evaluation of pain at 24 hours after surgery</measure>
    <time_frame>at postoperatively 24 hours</time_frame>
    <description>The doctor blinded to the investigation will visit patients. The pain will be assessed at rest and at coughing using visual analogue scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The consumption of analgesics</measure>
    <time_frame>at postoperatively 24 hours</time_frame>
    <description>The total amount of opioids (IV morphine) used for 24 hours after surgery will be recorded and compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The consumption of intraoperative opioids</measure>
    <time_frame>From the induction of anesthesia till the emergence of anesthesia, an expected average of 4 hours</time_frame>
    <description>The total amount of intraoperative opioids (IV remifentanil) will be recorded and compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The side effects of opioids after surgery</measure>
    <time_frame>During 72 hours after the end of surgery</time_frame>
    <description>Any side effects of opioids including nausea, vomiting, dizziness, sedation, headache, pruritus and respiratory depression will be recorded.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Prostatic Neoplasms</condition>
  <arm_group>
    <arm_group_label>The ITM group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The postoperative pain management includes both the intrathecal morphine injection and the intravenous patient-controlled analgesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The IV-PCA group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The postoperative pain management includes only the intravenous patient-controlled analgesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>The intravenous patient-controlled analgesia</intervention_name>
    <description>The intravenous injection of morphine using the patient-controlled analgesia machine</description>
    <arm_group_label>The ITM group</arm_group_label>
    <arm_group_label>The IV-PCA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>The intrathecal morphine injection</intervention_name>
    <description>A single injection of morphine intrathecally</description>
    <arm_group_label>The ITM group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for the open nephrectomy

        Exclusion Criteria:

          -  Patients with renal insufficiency

          -  Patients with coagulopathy

          -  History of any neurologic disorder

          -  History of recent infection in 2 weeks

          -  History of drug abuse

          -  Patients who cannot understand the usage of th intravenous patient-controlled
             analgesia

          -  Patients using opioids due to the chronic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Deok-Man Hong, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University of Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University of Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>July 1, 2015</last_update_submitted>
  <last_update_submitted_qc>July 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Deok Man Hong</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Prostatic Neoplasms</keyword>
  <keyword>Laparoscopy</keyword>
  <keyword>Injections, Spinal</keyword>
  <keyword>Morphine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

